ArticleOpen forum infectious diseases2021

US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19.

Robert W Finberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.